Safety and Efficacy of a “High and Low Molecular Weight Hyaluronic Acid Hybrid Complex” Injection for Face Rejuvenation
Journal of Cosmetic Dermatology · 2025-04 · 24 (4)
DOI: 10.1111/jocd.70117 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 09.04.2025. Verfasst von Taraneh Yazdanparast und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermal Fillers, Hyaluronic Acid, Rejuvenation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hyaluronic acid (HA)‐based formulations could have remarkable efficacy in treating a wide range of skin defects, including skin aging. The purpose of the study was the evaluation of the clinical safety and efficacy of a high and low molecular weight HA hybrid complex injection for skin rejuvenation.
Method
In this single‐arm, before‐and‐after clinical study, 20 subjects with wrinkled, dry, or rough skin were enrolled. They received two treatment sessions, each of 2 mL of stabilized high‐ and low‐molecular‐weight HA through intradermal injections in five bioaesthetic points with an interval of 4 weeks. Efficacy assessment measures included biophysical and sonographic parameters and the Global Aesthetic Improvement Scale (GAIS) score. Pain assessment, safety profile, and subject satisfaction were also reported.
Results
A significant improvement in skin firmness was demonstrated in both follow‐up visits. The Transepidermal water loss (TEWL) and the dermis ecodensity improved significantly in the first follow‐up visit. A statistically significant increase in the dermis thickness was seen in the second follow‐up visit. The median GAIS score indicated an average improvement of 51%–75%. The median overall satisfaction score was 7 and 6 in the first and second follow‐up visits. No important side effects were observed. The average pain VAS score was 2 out of 10.
Conclusion
This new HA‐based formulation is a safe and efficient treatment option to restore the vitality and turgidity of the skin. Trial Registration ClinicalTrials.gov identifier: IRCT20150101020514N17 with ethics code IR.TUMS.TIPS.REC.1401.083
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
- Medical Department, Orchid Pharmed Company, Tehran, Iran.
ORCID-Profile: Aniseh Samadi
Zitieren
APA
Yazdanparast, T., Ayatollahi, A., Samadi, A., Sabzvari, A., Kafi, H., & Firooz, A. (2025). Safety and Efficacy of a “High and Low Molecular Weight Hyaluronic Acid Hybrid Complex” Injection for Face Rejuvenation. Journal of Cosmetic Dermatology, 24(4). https://doi.org/10.1111/jocd.70117
Vancouver
Yazdanparast T, Ayatollahi A, Samadi A, Sabzvari A, Kafi H, Firooz A. Safety and Efficacy of a “High and Low Molecular Weight Hyaluronic Acid Hybrid Complex” Injection for Face Rejuvenation. Journal of Cosmetic Dermatology. 2025;24(4). doi:10.1111/jocd.70117
BibTeX
@article{Yazdanparast2025,
author = {Yazdanparast, Taraneh and Ayatollahi, Azin and Samadi, Aniseh and Sabzvari, Araz and Kafi, Hamidreza and Firooz, Alireza},
title = {Safety and Efficacy of a “High and Low Molecular Weight Hyaluronic Acid Hybrid Complex” Injection for Face Rejuvenation},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {4},
doi = {10.1111/jocd.70117}
}
EUVIMED